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ABSTRACT OF THE THESIS 
 
Coping as a Mediator between Symptom Burden and Distress in 
Lung Cancer Patients 
 
by 
Spring F. Gehring 
Doctor of Philosophy, Graduate Program in Psychology 
Loma Linda University, June 2017 
Dr. Holly E. R. Morrell, Chairperson 
 
 
Lung cancer is considered the leading cause of cancer death worldwide. An 
estimated 224,390 new cases of lung cancer are expected to be diagnosed and 158,080 
Americans are expected to die from lung cancer in 2016 (National Institutes of Health, 
2016; Siegel, Miller, & Jemal, 2016). Lung cancer patients also report the highest levels 
of psychological distress and symptom burden than any other forms of cancer (Linden, 
Vodermaier, MacKenzie, & Greig, 2012). Given the prevalence and impact of lung 
cancer, it is imperative to address the emotional toll this diagnosis can have on those 
suffering with the disease to develop helpful strategies for those coping with lung cancer.  
The goal of this study is to determine how much lung cancer patients’ symptom burden 
affects their level of distress, and how much of this effect is mediated by approach and/or 
avoidance coping styles. Adults (N = 109, 57% female,) with an average age of 67 (SD = 
10.1) diagnosed with lung cancer completed a questionnaire assessing for physical and 
psychological functioning at two medical centers in Southern California. Results: There 
was a significant positive relationship between total symptom burden and distress. 
Avoidance coping was a significant mediator of the relationship between total symptom 
burden and distress. Approach coping was not a significant mediator of this relationship. 
ix 
Conclusions: Results suggest that a patient experiences more distress as his/her symptom 
burden increases, and this effect is partially explained by engaging in avoidant coping. 
Therefore, it is important to find ways to help patients cope more effectively to reduce 
their levels of stress. The findings of this study show the importance of continued 
research to find effective coping strategies and as well to inhibit patients from engaging 
in an avoidant coping style.
 1 
CHAPTER ONE 
INTRODUCTION 
 
Lung cancer is considered the most common cancer worldwide, accounting for 
1.37 million deaths per year (American Lung Association, 2014). The National Institutes 
of Health (NIH) project that an estimated 158,080 people are expected to die in the 
United States from lung cancer in 2016. Consequently, the NIH estimates that cancer care 
cost in the United States was $147.5 billion in 2015, and $13.4 billion of those costs were 
due to lung cancer. Furthermore, lung cancer accounts for 26.5% of all cancer deaths 
(NIH, 2016). The American Cancer Society (2016) concludes that lung cancer is “by far 
the leading cause of cancer death among both men and women.” Lung cancer is also 
considered to have a lower five-year survival rate (16.6%) than other leading types of 
cancer such as breast and prostate cancer (American Cancer Society, 2014). Although 
survival rates are higher when the disease is detected when it is still localized to the lungs 
(15.3%), this survival rate drops dramatically to 3.9% when the cancer has spread to 
other organs (American Lung Association, 2014). Furthermore, lung cancer is often not 
detected until a later stage when the cancer has often already metastasized or spread to 
other parts of the body (Jemal et al., 2011).  
In addition to high commonality, mortality rate, and cost of the disease, it has also 
been found that lung cancer patients may also suffer significantly more distress than 
patients with other cancer diagnoses (Akechi et al., 2001). It has been theorized that these 
results could be due to the poor prognosis of the disease, in addition to the stigma 
attached to commonly held beliefs as to the origins of the disease (Zabora et al. 2001). 
Since lung cancer has a strong association with smoking, the belief that lung cancer is 
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due to a controllable behavior (smoking) and/or that patients have personal responsibility 
for their condition contributes to patients’ feelings of regret and self-blame, regardless of 
past smoking behavior (Chapple, Ziebland, & McPherson, 2004).  
 
Symptom Burden and Distress 
Lung cancer patients face a barrage of difficulties related to their diagnosis 
causing emotional strain. For example, severe physical symptoms (pain, dyspnea, fatigue 
and cough), intrusive treatments (surgery, chemotherapy, and radiotherapy), and poor 
prognosis can lead to high levels of psychological distress (Linden et al., 2012; 
Shellekens et al., 2016). The high levels of distress can manifest as high rates of 
depressive disorders (11%; Linden et al., 2012) and other psychiatric disorders (15-19%; 
Akechi et al., 2001). Because lung cancer patients undergo so much physical and 
emotional distress, they often experience decreased quality of life, high rates of medical 
care attrition, prolonged hospital stays, and lower rates of survival (Shellekens et al., 
2016). This all adds to the total symptom burden that is experienced by patients and can 
lead to distressing emotional and behavioral issues such as fear of recurrence, fatigue, 
sleep difficulties, and perceived vulnerability (Cho, Park, & Blank, 2013). 
The level of distress or total symptom burden experienced by a patient can 
significantly impact his/her quality of life and ability to function (Aranson, 1991). A 
general diagnosis of any type of cancer can impact patients emotionally, socially, and 
physically (Plunket, Chrystal, & Harper, 2003), and can predict higher levels of 
depression, social withdrawal, and higher rates of mortality (Faller et al., 1999). In a 
review by Fletcher et al. (2012) analyzing the family caregiving experience of those with 
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cancer, patient pain, depression, and agitation (Weitzner et al., 2000), anxiety (Cotrim & 
Periera, 2008), neuropsychiatric disorders (Sherwood et al., 2006), and fatigue (Fletcher 
et al., 2009) were found to all contribute to the distress levels of patients and their 
families. In fact, a person’s level of distress can even effect or interfere with a treatment’s 
effectiveness, which has been observed in multiple foundational studies (Parsons, Bova, 
& Million, 1980; Parsons, Thar, Bova, & Millon, 1980). More specifically, multiple 
studies have shown that there is a significant relationship between symptom burden and 
level of distress in lung cancer patients (Akin, Can, Aydiner, Osdilli, & Durna, 2012; 
Iyer, Roughle, Rider, & Taylor-Stokes, 2014; Mohan, et al., 2011; Yang et al., 2012). 
More recently, Gonzalez and Jacobsen (2012) found that lung cancer patients with higher 
levels of perceived stigma, avoidant coping, poor social support, and dysfunctional 
attitudes were significantly more likely to exhibit higher levels of depressive symptoms. 
Lung cancer patients also report higher rates of the above-mentioned stressors and 
emotional distress than patients with other forms of cancer, mostly due to the poor 
prognosis (Shellekens et al., 2016).   
 
Coping Strategies 
Coping strategies may in part explain the relationship between symptom burden 
and distress among cancer patients, and thus may represent important targets for 
psychosocial interventions for this population. Lazarus and Folkman (1984) developed a 
model of stress and coping that serves as the most widely accepted and studied 
explanation of how people appraise a stressful situation and then generate a coping 
response. Their Transactional Model of Stress and Coping is described as a bidirectional 
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process that involves the introduction of environmental stressors perceived by an 
individual and the individual’s appraisal and response to the stressors. Appraisal can be 
influenced by many personal factors and can be conscious or unconscious. If a perceived 
stressful event occurs, this triggers a cognitive appraisal of the situation which then leads 
to a coping response (cognitive and/or behavioral) to manage the stressful situation 
(Hulbert-Williams, Morrison, Wilkinson, & Neal, 2012). For example, if the phone rings 
while a person is driving, the person needs to decide whether to answer the phone and 
compromise their driving ability or ignore the call and continue focusing on the task of 
driving. This cognitive appraisal can be further compromised depending on the origin of 
the call, the emotional state of the driver, and even the conditions of the road, and lead to 
more perceived stress on the part of the driver. In the case of cancer, these coping 
strategies (cognitive and behavioral responses to stressors) are in response to each 
individual patient’s appraisal of his/her diagnosis.  
According to Lazarus and Folkman (1984), there are different types of coping 
such as problem focused coping and emotion focused coping. Problem focused coping is 
a response that is geared toward resolving the stressful situation or taking action to 
alleviate the stress and change the situation. Engaging in problem focused coping might 
entail removing the source of the stress or establishing an action plan to combat the 
stressful situation. For example, if students know they are on the borderline of a poor 
grade in a class, they might look for ways to fix their grades by hiring a tutor or asking 
for feedback from the professor, essentially taking an active role in combating the 
stressor to resolve the negative emotions (Pavani, Vigouroux, Kop, Congard, & Dauvier, 
2016). Alternatively, emotion focused coping seeks to resolve the emotional response to a 
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stressor rather than focusing on eliminating or resolving the stressor itself. An emotion 
focused coping style might entail analyzing and confronting the feelings that arise when 
faced with the stressor (Lazarus & Folkman, 1987). For example, when patients are 
diagnosed with a terminal illness, their reaction is often emotion focused since the main 
stressor, the illness, cannot be eliminated or changed and they may seek to reduce their 
feelings of fear, anxiety, or depression by seeing a therapist, journaling, or talking with 
friends about their feelings. In addition, problem focused coping is typically utilized 
when an individual perceives that something can be changed about the outcome whereas, 
emotion focused coping is typically employed when an individual perceives that a 
stressor is something that must be endured as opposed to fixed or altered (Carver, 
Scheier, & Weintraub, 1989).  
 Roth and Cohen (1986) took Lazarus and Folkman’s model of stress further and 
identified two common types of coping strategies that people tend to employ: approach 
and avoidance coping. These two coping strategies define a basic desire for humans to 
choose to either approach or avoid a situation. An approach strategy would be described 
as a likelihood of moving towards or engaging in an issue in hopes of obtaining a 
potential positive outcome (Elliot, Thrash, & Murayama, 2011), whereas a negative 
approach would be described as a general strategy of avoidance in an effort to stay away 
from a potentially negative outcome. Essentially, an avoidant strategy is the act of 
behaviorally disengaging or escaping from the threat or stress that is provoking the 
distress (Carver & Scheier, 1994). For example, a person with a disposition towards 
approach coping would focus on trying to do well in school, whereas a person with a 
disposition towards avoidance coping would try to avoid doing poorly in school (Elliot, 
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Sheldon, & Church, 1997). Additionally, approach and avoidance coping, in the face of 
terminal illness, are typically categorized as emotion focused coping strategies as they are 
utilized to resolve the negative feelings that arise in a stressful situation due to the 
uncontrollable outcome (Wright, 2012). However, some approach strategies such as 
problem solving, or researching methods to control pain, and utilizing avoidant methods 
such as distraction to reduce physical pain could be considered problem focused (Carver 
& Scheier, 1994).    
Roth and Cohen (1986) not only defined avoidance coping as a general 
orientation away from threat, but also argued that this style could be advantageous for 
coping with short-term problems, since the avoidance of stress and prevention of anxiety 
could be beneficial. For example, avoidance coping strategies are effectively and 
regularly used by athletes during sporting events (Nicholls et al., 2006), as well for 
athletes recovering from an injury such as those suffering from anterior cruciate ligament 
injuries (Carson & Polman, 2009). However, recent research as to the benefit of 
avoidance coping in regards to cancer is minimal to nonexistent. Overall, avoidance 
coping can prove maladaptive for long-term problems due to its association with 
increased emotional and physical distress. Approach coping, however, is associated with 
problem acceptance and more help seeking behavior, proving more adaptive for more 
chronic problems (Roth & Cohen, 1986). Approach coping is considered advantageous 
when coping with long-term stressors because of its adaptive nature in the face of 
uncontrollable outcomes. However, approach coping can also prove maladaptive if 
patients stagnate in the ventilation of affect or the venting/expression of feelings, and do 
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not attempt to emotionally progress beyond this state (Quartana, Laubmeier, & Zakowski, 
2006). 
 In specific regards to those suffering with a cancer diagnosis, approach and 
avoidance coping can be conceptualized as reactions on the part of the patient to either 
confront and “approach” the diagnosis or ignore and avoid the diagnosis and its 
implications. For example, those with an approach focus response may ask more 
questions of their doctor, plan ahead, and engage in positive appraisal and direct action to 
confront their diagnosis. In comparison, those with an avoidant strategy may turn to 
distracting themselves with work and other activities, or daydreaming; deny existence of 
the cancer diagnosis; and reduce effort in confronting symptoms.   
 Coping strategies have been shown to predict health outcomes among cancer 
patients in general, and in lung cancer patients more specifically (Zeiderner & Saklofske, 
1996). Multiple studies have shown that the form of coping strategies that cancer 
survivors apply can predict their quality of life even more than medical or other treatment 
factors (Avis, Crawford, & Manuel, 2005; Lehto, Ojanen, & Kellokumpu-Lehtinen, 
2005; Wenninger et al., 2013). In addition, recent findings have indicated that avoidance 
oriented coping may predict increases in cancer-related intrusive thoughts (Bauer, Yanez, 
Jorge, & Maggard-Gibbons, 2016). In a study analyzing coping strategies of lymphoma 
patients, positive changes such as benefit finding, stress-related growth, and adversarial 
growth, were associated with an approach coping style consisting of positive reappraisal, 
acceptance, and active coping. Conversely, an avoidant coping strategy such as 
distraction was found to be related to more negative changes such as diminished 
relationships, heightened awareness of physical limitations, and uncertainty in life 
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(Schroevers, Kraaij, & Amefski, 2011). It has also been found that survivors of testicular 
cancer who engage in avoidant coping strategies endorse more somatic and psychological 
symptoms than those that use an approach coping strategy (Rutskij et al., 2010). More 
negative expression or avoidant strategies were also associated with higher levels of grief 
in young adults dealing with an advanced stage of cancer (Trevino et al., 2013). 
Specifically among patients with lung cancer, studies have shown that coping styles can 
predict levels of psychological distress such as helplessness and hopelessness (Akechi et 
al., 1998), social withdrawal, depression and hope levels (Faller et al., 1995), and even 
survival rates (Faller et al., 1999). Overall, avoidant strategies are associated with poorer 
outcomes in all types of cancer related diagnoses.  
Studies also suggest that, compared to avoidance coping, approach coping is 
associated with better outcomes in individuals with a variety of medical conditions, 
including lung cancer. Roesch and colleagues conducted multiple meta-analyses 
analyzing the associations among coping strategies and different illnesses such as 
diabetes (Duangdao & Roesch, 2008), prostate cancer (Roesch et al., 2005), and people 
coping with chronic illness (Roesch & Weiner, 2001). The results from these studies 
indicated that an approach coping method is associated with better psychological 
adjustment, whereas avoidant coping is associated with poorer psychological adjustment. 
In a review of these methods by Moskowitz et al. (2009), approach coping, overall, 
correlated with better outcomes, such as increased positive affect, better health behaviors, 
and better physical health. Alternatively, avoidance coping was related to poorer 
outcomes such as substance abuse, social isolation, and increased negative affect. With 
respect to coping with HIV, Moskowitz et al. (2009) found that approach coping is 
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correlated with higher levels of positive affect, better health behaviors, and better 
physical health, and avoidance coping is associated with the opposite effects. In addition, 
an approach oriented coping strategy in those diagnosed with lung cancer can lead to 
fewer depressive symptoms and an avoidant style can predict more severe depressive 
symptoms (Walker, Zona, & Fisher, 2006). Positive, approach-oriented coping strategies 
such as positive reframing and emotional approach coping are associated with a greater 
likelihood of lung cancer patients being able to identify benefits within their experience, 
such as posttraumatic growth and benefit finding (Thornton, et al., 2012). Examples of 
benefit finding would be finding greater spiritual meaning or deepening connections in 
interpersonal relationships due to the diagnosis. Identifying these benefits is in turn 
correlated with lower perceived cancer-related stress.  
The bulk of research has shown that coping strategies, including avoidance and 
approach, can predict psychological adjustment, and more specifically that approach 
coping is associated with more positive outcomes whereas, avoidant coping is associated 
with more negative outcomes for patients confronting a terminal illness (Moskowitz et 
al., 2009). However, as stated above, there is a relative dearth of research examining 
whether approach or avoidance coping can explain, or mediate, the relationship between 
symptom burden and distress specifically among lung cancer patients (Moreno, Bauer, 
Jorge, Yanez, & Maggard-Gibbons, 2016). Much of the research has focused on 
describing the different types of coping strategies (Moreno, Bauer, Jorge, Yanez, & 
Maggard-Gibbons, 2016), analyzing the effect of coping strategies on social support or 
caregivers (Fletcher, Miaskowski, Given, & Schumacher, 2012; Islam et al., 2016; 
Schroevers, Kraaij, & Garnefski, 2011; Walker, Zona, & Fisher, 2006), and assessing 
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stigma in relation to lung cancer, such as how feelings of regret and stigmatization are 
associated with poor psychological outcomes (Criswell, Owen, Thornton, Stanton, 2015; 
Gonzalez & Jacobsen, 2012) for those with lung cancer. However, analysis specifically 
addressing the effect of avoidant versus approach coping strategies and how these 
strategies mediate the effect of distress on symptom burden lacking.  
 
Hypothesis 
Therefore, the authors of the current study aim to examine whether type of coping 
strategy (approach and avoidance) mediates the relationship between a patient’s total 
symptom burden and distress in a sample of patients with lung cancer. Our hypothesis is 
that there will be a significant positive relationship between a patient’s total symptom 
burden and distress, and that this relationship will be mediated by approach and 
avoidance coping.  Essentially, as a participant’s total symptom burden increases, so will 
his or her level of distress. Furthermore, approach coping will be associated with a lower 
level of distress and avoidance coping will be associated with a higher level of distress. 
 
  
 11 
CHAPTER TWO 
METHODS 
 
Participants 
 Participants will include 109 adults (57% female) with a mean age of 67 (SD = 
10.71).  Of the participants, 82% were Caucasian, 7% Asian, 6% Hispanic, and 5% 
African American. A majority of the participants were married (65%), while 7% were 
single, 14% were divorced or separated, and 14% were widowed. The participants were 
all suffering from nonsmall cell or small cell lung cancer:15% were in stage one, 8% in 
stage two, 18% in stage three, and 31% in stage four; 28% were not sure of their stage of 
cancer.  
 
Materials 
Demographic Variables 
Researchers asked patients to report their age, gender, ethnicity, marital status, 
education level, and stage of lung cancer. 
 
Coping style 
Participants’ coping style was assessed by Carver et al.’s (1989) measure named 
COPE.  This measure was developed to assess for the different ways that people respond 
to stress. The 60-item measure assesses a variety of coping styles and strategies. For this 
study, two COPE subscales were summed to create an approach-focused coping scale: 
coping through planning such as “I take additional action to try to get rid of the problem,” 
and active coping efforts such as “I concentrate my efforts on doing something about it” 
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(four questions, α = 0.84). The subscales of mental disengagement (e.g., “I turn to work 
or other substitute activities to take my mind of things”), behavioral disengagement (e.g., 
“I just give up trying to reach my goal”), and denial (e.g., “I say to myself ‘this isn’t 
real’”) were combined to create an avoidant coping scale by summing all scores to create 
a total subscale score (12 items; α = 0.71). All questions were rated on a Likert scale 
ranging from 1 (‘I don’t do this at all’) to 4 (‘I do this a lot’). These approach and 
avoidance coping subscales were constructed based on recommendations from previous 
studies (Criswell, Owen, Thornton, Stanton, 2015; Sanders et al., 2010; Thornton et al., 
2012). 
 
Distress 
Distress was measured by one question referred to as “The Distress 
Thermometer” (DT). This item was created to asses for patients’ level of distress 
experienced in the last week.  Patients were instructed to “circle the number (0–10) that 
best describes how much distress [they] have been experiencing in the past week, 
including today.”  The DT was developed specifically for patients with cancer to quickly 
and easily screen for general distress (Schellekens et al., 2016), and it is notable for its 
sensitivity and ability to identify clinically significant distress levels (Roth et al., 1998). 
 
Symptom Burden 
The Memorial Symptom Assessment Scale – Short Form (MSAS-SF) was used to 
assess for patients’ level of burden associated with lung cancer symptoms. The twelve 
symptoms that were assessed were pain, lack of energy, cough, dry mouth, nausea, 
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shortness of breath, lack of appetite, difficulty swallowing, dysgeusia, weight loss, 
constipation, and insomnia (Chang et al., 2000). A five-point Likert scale was used to 
assess for how much each symptom bothered the participant in the last week with scale 
anchors of zero for “no symptoms at all,” and 4 for “almost constantly.” In the present 
study, a total Symptom Burden score was created by using the twelve symptoms that 
assessed for the how much patients were bothered by present lung cancer symptoms. 
Patient’s responses were summed across item ratings to create a total Symptom Bother 
score (Cronbach’s α = 0.85; Sanders et al., 2010). When used with cancer populations, 
the MSAS-SF shows good convergent validity (Chang et al., 2000). 
 
Procedure 
All participants were adult (over the age of 18) men and women diagnosed with 
primary carcinoma of the lung, specifically nonsmall cell and small cell lung cancer, and 
were recruited from either Loma Linda University Medical Center (LLUMC) or City of 
Hope (CoH). To be eligible, subjects had to be able to read and write in English, could 
not be suffering from a mesothelioma diagnosis, and had to feel well enough to take part 
in the study. In addition, CoH participants had to have received their diagnosis within six 
months prior to joining the study, although participants from LLUMC were not excluded 
based on time since diagnosis.  
Each site engaged in different data collection procedures. Participants at LLUMC 
were recruited from the cancer registry and all patients diagnosed with lung cancer in the 
last 12 months were contacted via mailed pamphlets. After the pamphlets were mailed 
out, patients received a phone call assessing for interest in the study. If a patient was 
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interested, he or she was then mailed the questionnaire. Of those patients who received 
the mailed information pamphlet, approximately 40% were successfully contacted by a 
researcher. Sixty-three percent of those contacted by the researcher gave consent for 
participation in the study and 72% returned the questionnaire.  
CoH patients were assessed for eligibility by the Project Coordinator (PC), clinic 
staff, and the attending physician prior to their clinic visit. After this initial screening, 
patients then met with the PC where the study was explained to them and consent was 
obtained. All CoH patients returned their completed questionnaires by mail. Of all the 
eligible patients, COH staff were able to contact 62% and obtain consent from 98.4% of 
those contacted. In addition, all of those who completed the questionnaire were 
compensated (CoH - $20 and LLUMC - $10). These recruitment procedures are the same 
as those presented in Sanders et al. (2010) and Criswell et al. (2016). 
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CHAPTER THREE 
CONCLUSION 
 
Results 
Bivariate Pearson correlations were run to determine which demographic and 
medical characteristic variables (age, years of education, gender, and stage of cancer) 
would be included as covariates in a multiple mediation model. Years of education (p > 
.05), gender (p > .05), and stage of cancer (p >.05) were not significantly associated with 
levels of distress; however, age (r = -.230, p < .001) was significantly inversely 
associated with levels of distress. Therefore, age was added as a covariate in the multiple 
mediation model.  
Using bootstrapping to conduct a multiple mediation analysis, we tested whether 
total symptom burden would predict a participant’s level of distress and whether this 
effect would be mediated by approach and/or avoidance coping strategies, while 
controlling for the effect of age on distress levels. The mediation model was significant, 
F(4,182) = 44.72, R2 = .48, p < .001 (see Figure 1). The total effect of symptom burden 
on distress was significant, t = 11.76, p < 001. The direct effect of total symptom burden 
on distress in the presence of the two mediators (approach and avoidance coping) was 
significant as well, (c’ = 2.17, p < .05). However, the effect of age as a covariate was not 
statistically significant, (p > .05). There was a significant positive association between 
total symptom burden and avoidance coping (a = 2.11, p < .001), and a significant 
positive association between avoidance coping and distress (p < .004). Avoidance coping 
(M = 20.43, SD = 5.26) was a significant mediator of the relationship between symptom 
burden and distress, after controlling for the effects of age and approach coping. As total  
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Figure 1. Results of analysis testing avoidance coping and approach coping as mediators 
of the relationship between total symptom burden and distress among patients with a 
diagnosis of lung cancer. (All effects are significant at p < .05.) 
 
 
symptom burden increased by one point, distress increased by .182 points through the 
effect of avoidance coping (ab = .182, 95% CI [.067, .347], p < .05). In addition, 
avoidance coping was a significantly stronger mediator than approach coping (b = .2090, 
95% CI [.070, .396], p < .05). Approach coping (M = 21.44, SD = 5.86) was not a 
significant mediator, p < .001 (see Table 1). More specifically, symptom burden did not 
significantly predict approach coping, and also did not predict distress, ps > .05. A post 
hoc power analysis was conducted using the software package GPower (Erdfelder, Faul, 
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& Buchner, 1996). The sample size of 109 was used for the statistical power analyses and 
a three predictor variable equation was used as a baseline. The recommended effect sizes 
used for this assessment were as follows: small (f 2 = .02), medium (f 2 = .15), and large (f 
2 = .35). The alpha level used for this analysis was .05. The post hoc analyses revealed 
the statistical power for this study was .20 for detecting a small effect, whereas the power 
exceeded .93 for the detection of a moderate to large effect size. Thus, there was more 
than adequate power (i.e., power ≥ .80) at the moderate to large effect size level, but less 
than adequate statistical power at the small effect size level. 
 
 
Table 1. Results of Multiple Mediation Analysis Predicting Distress from  
Total Symptom Burden 
Mediated Effect Point Estimate SE 95% BCI 
    
Total Indirect Effect .1558 .0637 [.0026, .3283] 
    
Avoidance Coping .1824 .0551 [.0671, .3476] 
    
Approach Coping -.0266 .0532 [-.1437, .0290] 
    
Contrast of avoidance 
versus approach  .2090 .0876 [.0707, .3956] 
   Note. Significant effects are in bold 
 
Discussion 
The goal of the current study was to examine whether the relationship between 
lung cancer patients’ levels of distress and symptom burden was mediated by the use of 
coping strategies (approach and avoidance). As hypothesized, there was a significant 
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relationship between total symptom burden and distress: as a patient’s total symptom 
burden increased so did his or her levels of distress. As hypothesized, avoidance coping 
was a significant mediator of the relationship between symptom burden and distress, in 
that participants’ level of distress increased with their level of total symptom burden 
through avoidance coping. However, contrary to our hypothesis, approach coping did not 
significantly mediate the relationship between symptom burden and distress.   
As mentioned above, a significant relationship between total symptom burden and 
distress was found. This confirms previous research that the greater symptom burden a 
patient experiences, the higher his or her levels of distress will be (Linden et al., 2012; 
Shellekens et al., 2016). As a result, it can be postulated that one’s approach towards 
coping with symptom burden may influence distress. This has important implications for 
clinical application, specifically in a health related psychological practice, because 
clinicians and doctors can look at the reduction of symptom burden as a means for 
reducing distress when applicable.  
Avoidance coping mediated the effect of symptom burden on distress, and was 
associated with a higher level of distress. More specifically, greater symptom burden was 
associated with greater avoidance coping, and greater avoidance coping was in turn 
associated with greater distress. This result suggests that, in coping with their diagnosis 
and its related symptom burden using avoidant strategies, lung cancer patients may 
experience more distress. This finding confirms previous research examining the effects 
of avoidance coping in the face of terminal illness and relates it specifically to those with 
lung cancer (Schroevers, Kraaij, & Amefski, 2011). Perhaps patients who deny their 
diagnosis or attempt to ignore symptoms end up feeling more stressed due to the 
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accumulation and severity of symptoms that they can no longer ignore. Essentially, they 
may have a harder time ignoring or denying their disease, thus creating more distress for 
themselves as their symptoms increase and their prognosis becomes worse. In addition, 
perceived loss of control when facing a terminal diagnosis could be compounded by an 
avoidant coping style, thus leading to higher levels of distress.  This could be explained 
by the idea that denying the existence of their cancer diagnosis or attempting to ignore 
symptoms leads to less behavioral activation in regards to treatment, higher levels of 
intrusive thoughts (Bauer, Yanez, Jorge, & Maggard-Gibbons, 2016), more psychological 
symptoms (Rutskij et al., 2010), and overall poorer outcomes (Moskowitz et al., 2009; 
Roesch et al., 2005). The implications for this finding are important for developing 
effective treatment modalities for those with lung cancer, since coping strategies can 
predict quality of life more so than medical or other treatment factors, (Avis, Crawford, 
& Manuel, 2005; Lehto, Ojanen, & Kellokumpu-Lehtinen, 2005; Wenninger et al., 2013). 
Given this information, some ideas for future application include providing 
psychoeducation upon diagnosis, or shortly after, as to the long-term effects of avoidance 
on wellbeing.  
The fact that approach coping did not significantly mediate the relationship 
between symptom burden and distress was surprising, given the amount of literature 
attesting to approach coping being associated with better outcomes (Duangdao & Roesch, 
2008). The results of the current study suggest that symptom burden is not associated 
with approach coping. Therefore, symptom burden only predicts avoidance coping and 
not approach coping among lung cancer patients. Approaching the illness with coping 
through planning and other more active strategies does not seem to mitigate the stress that 
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a patient feels, but ignoring or denying the existence of lung cancer does appear to 
increase stress. Therefore, the results suggest that an approach coping strategy does not 
explain how symptom burden influences distress. Additionally, approach coping does not 
appear to affect the level of distress a person with lung cancer feels due to their burden of 
symptoms. This could be due to the idea that symptoms such as pain, coughing, lethargy, 
and invasive treatments exist regardless of the coping strategy that is employed, and 
therefore expecting approach coping to mediate the relationship between these symptoms 
and distress may be unrealistic. In addition, another potential explanation is that both 
coping through planning and active coping may not be effective strategies for those in 
later stages of cancer because of the severity of the disease and the poor prognosis at that 
point. Furthermore, patients may not believe these strategies to be useful due to the 
perceived hopelessness of their prognosis, in addition to the pain levels and fatigue they 
are experiencing. Correspondingly, it is possible that an approach coping strategy may 
take more physical effort on the part of the patient, causing him/her to feel overwhelmed 
and therefore inhibiting an approach strategy. This highlights the importance of a strong 
support system that includes both healthcare providers and caregivers. By educating 
members of these support systems on the importance and application of these coping 
strategies, more helpful and directed support could be provided for those suffering in later 
stages of lung cancer. In addition, an idea for future research would be to investigate 
more emotion based approach coping strategies to evaluate their impact on distress 
specifically for those in later stages.  
Furthermore, another idea for future research would be to analyze the impact of 
diagnosis timing on effectiveness of coping strategies. Essentially, the idea would be to 
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assess the coping strategies that lung cancer patients use at a variety of time points 
following their diagnosis, and then evaluate if this timing will have any effect on the 
strength of impact coping strategies have on distress. In addition, it would be helpful to 
examine the data to assess for the presence and effect of different types of coping 
strategies at different time points. Examining different time points could be helpful in 
assessing for how patients generally tend to employ coping strategies and assess for their 
impact and those specific times. For example, approach coping could be more commonly 
utilized at the beginning stages when patients are beginning to understand the impact of 
their diagnosis and perhaps more likely to engage in more active coping strategies, 
whereas avoidance coping maybe more commonly utilized in later stages of lung cancer 
when patients are potentially greater severity of their symptoms and poorer prognosis. It 
may also be useful to test avoidance and approach coping as moderators of the 
relationship between symptom burden and distress, because the strength of the 
relationship between symptom burden and distress may depend on the use of approach 
versus avoidance coping.  
The results of the current study should be interpreted in light of several 
limitations. First, there was a relative lack of diversity within the study sample. The 
participants of this study were primarily Caucasian and recruited from one geographic 
location. The lack of diversity within the population could affect the overall 
generalizability of the study. In addition, the cross-sectional design of this study only 
allows us to make inferences about association and not causation between symptom 
burden and distress and the corresponding mediators. Furthermore, the lack of a 
longitudinal design precludes drawing conclusions about the development and 
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application of coping strategies over time for those with lung cancer. In addition, coping 
strategies are often categorized as bidirectional (Lazarus & Folkman, 1984), and 
therefore this process of coping and outcomes my not be fully captured using a cross-
sectional design. Additionally, given the power analysis, non-significant effects might be 
the result of Type II error due to low power for detecting a small effect. Furthermore, 
coping strategy subscales were grouped based on previous research of archived data and 
my not truly encapsulate the full range of approach or avoidance coping strategies. 
Another limitation is that all of the data were based on self-report measures, and using 
self-report measures introduces the possibility of response bias. It is also possible that 
there is a confounding variable that would explain the lack of effect of approach coping 
on distress, such as hopelessness or fatigue.  
These findings suggest that coping strategies, specifically avoidance coping, can 
have a clinically significant influence on those diagnosed with lung cancer even in later 
stages. Because a lung cancer patient’s level distress, choice of coping strategy, and 
overall emotional wellbeing can have such a significant impact on quality of life and 
medical outcomes, it is imperative to research this idea further. In addition, this study 
shows the power of avoidance coping even over the impact of approach coping, which is 
important when developing effective treatment modalities. Early identification of 
patients’ preferred coping strategies by psychological screening or brief coping strategy 
surveys could help clinicians to identify patients with maladaptive coping strategies who 
could benefit from psychoeducation and social support. Identifying and treating such 
patient may improve their overall wellbeing and in the long run increase the effectiveness 
of medical treatments. 
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Overall, the findings from this study emphasize the importance of finding 
effective coping strategies to help those suffering with a lung cancer diagnosis. 
Additional studies are needed to replicate the findings of this study in a larger and more 
diverse sample, including continuing to assess how the adoption of an avoidance or 
approach coping style can affect emotional wellbeing, treatment outcomes, and overall 
quality of life for those with lung cancer. In addition, even though our findings regarding 
approach coping were contrary to our prediction, the findings still have clinical 
implications to aid clinicians when assessing helpful modalities to use for those with lung 
cancer. To know what does not work is just as important as knowing what does work. 
However, it is important to conduct additional research to replicate the current findings, 
to assess for why patients with lung cancer may be less likely to use approach coping, to 
determine whether lung cancer patients are more likely to use approach coping at 
different stages of their disease, and to identify any elements of approach coping that do 
have impact on emotional wellbeing in those with a lung cancer.  
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